Relief Products for Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate how different health and wellness products affect pain and overall health. Participants will receive one of three active products (Relief Active Product 1, Relief Active Product 2, or Relief Active Product 3) or a placebo (a product with no active ingredients) to compare results. It is ideal for individuals living in the U.S. who experience pain and seek improvement in their daily health. Participants must be willing to use an unknown product, which could be either active or placebo, for the trial's duration. As an unphased trial, this study offers a unique opportunity to explore new methods for improving health and managing pain.
Will I have to stop taking my current medications?
You may need to stop taking certain medications if they interact with the study products. The trial excludes people taking medications that have moderate or severe interactions with the study products, such as anticoagulants, antidepressants, and others listed in the criteria.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Relief Active Product 1, commonly used for pain relief, has been linked to rare cases of serious burns. Although these incidents are uncommon, they are important to mention. Generally, these products create a warming or cooling sensation without causing harm. Always follow the instructions carefully.
For Relief Active Product 2, specific safety information is not available. However, its inclusion in a study suggests some evidence of safety, as such trials typically occur only if earlier data indicate the product is relatively safe.
Relief Active Product 3 carries some warnings. Users should stop using it and consult a healthcare professional if symptoms persist or worsen after five days. Pregnant or breastfeeding individuals should also seek advice before using it.
In summary, while these products generally appear safe, it is important to follow instructions and monitor for any unusual reactions. Always consult a healthcare provider if there are any doubts.12345Why are researchers excited about this trial's treatments?
Unlike traditional pain relief treatments that often rely on opioids or NSAIDs, the Relief Active Products 1, 2, and 3 offer a fresh approach by potentially utilizing novel mechanisms or active ingredients. Researchers are excited because these treatments might target pain pathways differently, possibly reducing the risk of side effects commonly associated with standard options. Additionally, these products may offer a new delivery method, which could improve patient compliance and comfort. This innovative approach gives hope for more effective pain management solutions with fewer drawbacks.
What evidence suggests that this trial's treatments could be effective for pain?
This trial will evaluate the effectiveness of Relief Active Products 1, 2, and 3 in managing pain. Studies have shown promising results for these products. Specifically, research indicates that about 60% of participants using Relief Active Product 1 experienced moderate to substantial pain relief. Relief Active Product 2 also demonstrated effective results, with similar levels of relief reported. Relief Active Product 3 led to a noticeable decrease in pain, showing significant improvements compared to the start. Overall, these findings suggest that each product can significantly help reduce pain levels in participants.678910
Who Is on the Research Team?
Susan Hewlings
Principal Investigator
Radicle Science
Are You a Good Fit for This Trial?
Adults over 21 in the U.S. with pain or peripheral neuropathy, who could see at least a 30% improvement in health outcomes and are willing to take an unknown product (active or placebo). Excludes those in other trials, pregnant/breastfeeding individuals, heavy drinkers, non-English speakers without internet access, and those with certain medical conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the study product or placebo for 7 weeks, with self-reported data collected electronically
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Relief Active Product 1
- Relief Active Product 2
- Relief Active Product 3
- Relief Product Placebo Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
Radicle Science
Lead Sponsor